December 2-4, 2024 | Philadelphia, PA

Accelerate the Clinical Development of CAR-T, Treg & NK-Based Therapies with Improved Efficacy, Durability & Safety to Revolutionize Curative Care for Chronic Autoimmune Disease.

The Cell Therapy for Autoimmune Disease Summit is an unparalleled, pioneering event that unites leading experts and stakeholders in this exciting emerging field. This groundbreaking summit is a platform for sharing and discussing the latest advances in pre-clinical, translational, and clinical development across various cell types including CAR-T, Tregs, and NKs.

With 75+ attendees, 30+ world-class speakers including the likes of Cabaletta, Cartesian, Abata, and Bristol Myers Squibb delving into everything from new pre-clinical and clinical data, developing therapies with a high safety profile, innovative trial design, translational biomarkers, and over 6 hours of dedicated networking, ensure you join us to revolutionize the treatment landscape for chronic autoimmune diseases.

Our Immune Tolerance Research Lead, Rachel Hourigan, joins the line-up, setting the scene, with a comprehensive review of the past, present & future of the cell therapy autoimmune landscape, at 9:00 a.m. Find out more of her session details here; this is one not to be missed!